Sg Americas Securities, LLC Novavax Inc Transaction History

Sg Americas Securities, LLC

$17.2 Billion
Q2 2024

A detailed history of Sg Americas Securities, LLC transactions in Novavax Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 110,913 shares of NVAX stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

110,913

Previous 358,196 69.04%

Holding current value

$1.29 Million

Previous $1.71 Million 17.99%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$3.89 - $20.97 $961,930 - $5.19 Million	-247,283 Reduced 69.04%	110,913 $1.4 Million
Q1 2024 May 06, 2024	BUY	$3.76 - $6.02 $701,533 - $1.12 Million	186,578 Added 108.72%	358,196 $1.71 Million
Q4 2023 Jan 12, 2024	BUY	$4.8 - $7.67 $823,766 - $1.32 Million	171,618 New	171,618 $824,000
Q2 2023 Jul 10, 2023	SELL	$6.67 - $9.52 $2 Million - $2.85 Million	-299,201 Reduced 96.46%	10,994 $82,000
Q1 2023 Apr 28, 2023	BUY	$5.76 - $12.48 $1.07 Million - $2.32 Million	185,886 Added 149.54%	310,195 $2.15 Million
Q4 2022 Feb 02, 2023	BUY	$8.86 - $25.04 $818,345 - $2.31 Million	92,364 Added 289.13%	124,309 $1.28 Million
Q3 2022 Oct 31, 2022	BUY	$18.2 - $76.12 $292,656 - $1.22 Million	16,080 Added 101.36%	31,945 $581,000
Q2 2022 Jul 29, 2022	SELL	$36.28 - $75.29 $1.2 Million - $2.48 Million	-32,972 Reduced 67.51%	15,865 $816,000
Q1 2022 Apr 29, 2022	BUY	$69.73 - $142.9 $3.16 Million - $6.47 Million	45,262 Added 1266.07%	48,837 $3.6 Million
Q4 2021 Feb 07, 2022	SELL	$134.56 - $217.97 $3.58 Million - $5.81 Million	-26,638 Reduced 88.17%	3,575 $511,000
Q3 2021 Nov 01, 2021	BUY	$177.8 - $270.58 $2.97 Million - $4.51 Million	16,684 Added 123.32%	30,213 $6.26 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $1.02 Million - $2.18 Million	8,443 Added 166.0%	13,529 $2.87 Million
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $2.04 Million - $5.78 Million	-18,073 Reduced 78.04%	5,086 $922,000
Q4 2020 Feb 04, 2021	BUY	$78.74 - $139.5 $939,525 - $1.66 Million	11,932 Added 106.28%	23,159 $2.58 Million
Q3 2020 Nov 09, 2020	SELL	$79.44 - $178.51 $650,136 - $1.46 Million	-8,184 Reduced 42.16%	11,227 $1.22 Million
Q2 2020 Jul 20, 2020	BUY	$13.86 - $83.61 $110,602 - $667,207	7,980 Added 69.81%	19,411 $1.62 Million
Q1 2020 Apr 30, 2020	BUY	$3.93 - $16.0 $44,923 - $182,896	11,431 New	11,431 $155,000
Q4 2019 Jan 28, 2020	SELL	$3.69 - $5.22 $172,714 - $244,327	-46,806 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$4.02 - $7.84 $8,888 - $17,334	-2,211 Reduced 4.51%	46,806 $235,000
Q2 2019 Jul 29, 2019	BUY	$4.93 - $12.2 $241,653 - $598,007	49,017 New	49,017 $287,000

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $910M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Novavax Inc Transaction History